Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_provenance.
- NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_assertion description "[From studies of EGFR signaling pathways, inhibitory and modulating agents such as anti-EGFR antibodies and specific kinases inhibitors have been used to block the action of this pathway and prevent the development of TGFalpha-induced neoplasia and tumor formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_provenance.
- NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_assertion evidence source_evidence_literature NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_provenance.
- NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_assertion SIO_000772 10713694 NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_provenance.
- NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_assertion wasDerivedFrom befree-20150227 NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_provenance.
- NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_assertion wasGeneratedBy ECO_0000203 NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP731663.RAP_kq6B9LBC79Qqe-XM-li_yXN-Hmb-e5ePHZdSJKjOM130_provenance.